Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Kangtai Biological Partners with Pakistani Firm for Pneumonia Vaccine Expansion
January 19, 2025
Company
Deals
Shanghai-Based REMD Raises Series A+ Funding for Electroporation Device Expansion
January 19, 2025
Company
Drug
NMPA Approves Keverprazan for Duodenal Ulcers and Reflux Esophagitis
January 19, 2025
Company
Organon Reports Q4 and Full-Year 2022 Financials with Revenue Declines
January 19, 2025
Company
Deals
WinHealth Pharma Taps Baidu’s ERNIE Bot for Rare Disease Services
January 19, 2025
Company
Eppendorf to Start Construction on New Shanghai Production Site
January 19, 2025
Company
Deals
InnoCare Regains Rights to Orelabrutinib as Biogen Terminates Licensing Agreement
January 19, 2025
Company
Drug
AIM Vaccine Gains Approvals for COVID-19 mRNA Vaccine Trials in Pakistan
January 19, 2025
Company
Drug
Innovent Biologics Initiates Phase III CLEAR Study for Picankibart in Psoriasis
January 19, 2025
Company
Drug
Frontera Therapeutics Initiates FT-002 Clinical Study for X-Linked Retinitis Pigmentosa
January 19, 2025
Company
Drug
Kanghong’s KH617 Receives Orphan Drug Designation for Glioblastoma
January 19, 2025
Company
Drug
Luye Pharma’s BA2101 Begins Phase I Clinical Trial for Allergic Diseases
January 19, 2025
1
2
…
1,030
1,031
1,032
1,033
1,034
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?